SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-18-000074
Filing Date
2018-07-19
Accepted
2018-07-18 20:59:26
Documents
3
Period of Report
2018-07-13
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cti-item4018xkjuly2018fina.htm 8-K 35012
2 EXHIBIT 16.1 exhibit161ctibiopharm4d5.htm EX-16.1 1325
3 exhibit161ctibiopharm4d5001.jpg GRAPHIC 65344
  Complete submission text file 0000891293-18-000074.txt   127660
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 18959390
SIC: 2834 Pharmaceutical Preparations